2014 -- S 2518 | |
======== | |
LC004581 | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2014 | |
____________ | |
A N A C T | |
RELATING TO BUSINESSES AND PROFESSIONS-PHARMACIES | |
| |
Introduced By: Senators Doyle, Nesselbush, P Fogarty, and Lynch | |
Date Introduced: February 27, 2014 | |
Referred To: Senate Health & Human Services | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Section 5-19.1-2 of the General Laws in Chapter 5-19.1 entitled |
2 | "Pharmacies" is hereby amended to read as follows: |
3 | 5-19.1-2. Definitions. -- (a) "Board" means the Rhode Island board of pharmacy. |
4 | (b) "Change of ownership" means: |
5 | (1) In the case of a pharmacy, manufacturer, or wholesaler, which is a partnership, any |
6 | change which results in a new partner acquiring a controlling interest in the partnership; |
7 | (2) In the case of a pharmacy, manufacturer or wholesaler which is a sole proprietorship, |
8 | the transfer of the title and property to another person; |
9 | (3) In the case of a pharmacy, manufacturer, or wholesaler which is a corporation: |
10 | (i) A sale, lease exchange, or other disposition of all or substantially all of the property |
11 | and assets of the corporation; or |
12 | (ii) A merger of the corporation into another corporation; or |
13 | (iii) The consolidation of two (2) or more corporations, resulting in the creation of a new |
14 | corporation; or |
15 | (iv) In the case of a pharmacy, manufacturer, or wholesaler which is a business |
16 | corporation, any transfer of corporate stock which results in a new person acquiring a controlling |
17 | interest in the corporation; or |
18 | (v) In the case of a pharmacy, manufacturer, or wholesaler which is a non-business |
19 | corporation, any change in membership, which results in a new person acquiring a controlling |
| |
1 | vote in the corporation. |
2 | (c) "Compounding" means the act of combining two (2) or more ingredients as a result |
3 | of a practitioner's prescription or medication order occurring in the course of professional practice |
4 | based upon the individual needs of a patient and a relationship between the practitioner, patient, |
5 | and pharmacist. Compounding does not mean the routine preparation, mixing or assembling of |
6 | drug products that are essentially copies of a commercially available product. Compounding shall |
7 | only occur in the pharmacy where the drug or device is dispensed to the patient or caregiver and |
8 | includes the preparation of drugs or devices in anticipation of prescription orders based upon |
9 | routine, regularly observed prescribing patterns. |
10 | (d) "Controlled substance" means a drug or substance, or an immediate precursor of such |
11 | drug or substance, so designated under or pursuant to the provisions of chapter 28 of title 21. |
12 | (e) "Deliver" or "delivery" means the actual, constructive, or attempted transfer from one |
13 | person to another of a drug or device, whether or not there is an agency relationship. |
14 | (f) "Device" means instruments, apparatus, and contrivances, including their |
15 | components, parts, and accessories, intended: |
16 | (1) For use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man |
17 | or other animals; or |
18 | (2) To affect the structure or any function of the body of man or other animals. |
19 | (g) "Director" means the director of the Rhode Island state department of health. |
20 | (h) "Dispense" means the interpretation of a prescription or order for a drug, biological, |
21 | or device and, pursuant to that prescription or order, the proper selection, measuring, |
22 | compounding, labeling, or packaging necessary to prepare that prescription or order for delivery |
23 | or administration. |
24 | (i) "Distribute" means the delivery of a drug or device other than by administering or |
25 | dispensing. |
26 | (j) "Drug" means: |
27 | (1) Articles recognized in the official United States Pharmacopoeia or the Official |
28 | Homeopathic Pharmacopoeia of the U.S.; |
29 | (2) Substances intended for use in the diagnosis, cure, mitigation, treatment, or |
30 | prevention of disease in man, woman or other animals; |
31 | (3) Substances (other than food) intended to affect the structure or any function of the |
32 | body of man, woman or other animals; or |
33 | (4) Substances intended for use as a component of any substances specified in |
34 | subdivision (1), (2), or (3) of this subsection and section 5-19-1(16), but not including devices or |
| LC004581 - Page 2 of 5 |
1 | their component parts or accessories. |
2 | (k) "Equivalent and interchangeable" means having the same generic name, dosage form, |
3 | and labeled potency, meeting standards of the United States Pharmacopoeia or National |
4 | Formulary, or their successors, if applicable, and not found in violation of the requirements of the |
5 | United States Food and Drug Administration, or its successor agency, or the Rhode Island |
6 | department of health. |
7 | (l) "Intern" means: |
8 | (1) A graduate of an American Council on Pharmaceutical Education (ACPE) accredited |
9 | program of pharmacy; |
10 | (2) A student who is enrolled in at least the first year of a professional ACPE accredited |
11 | program of pharmacy; or |
12 | (3) A graduate of a foreign college of pharmacy who has obtained full certification from |
13 | the FPGEC (Foreign Pharmacy Graduate Equivalency Commission) administered by the National |
14 | Association of Boards of Pharmacy. |
15 | (m) "Legend drugs" means any drugs, which are required by any applicable federal or |
16 | state law or regulation to be dispensed on prescription only or are restricted to use by practitioners |
17 | only. |
18 | (n) "Manufacture" means the production, preparation, propagation, compounding, or |
19 | processing of a drug or other substance or device or the packaging or repackaging. |
20 | (o) "Non-legend" or "nonprescription drugs" means any drugs, which may be lawfully |
21 | sold without a prescription. |
22 | (p) "Person" means an individual, corporation, government, subdivision or agency, |
23 | business trust, estate, trust, partnership or association, or any other legal entity. |
24 | (q) "Pharmaceutical care" is the provision of drugs and other pharmaceutical services |
25 | intended to achieve outcomes related to cure or prevention of a disease, elimination or reduction |
26 | of a patient's symptoms, or arresting or slowing of a disease process. "Pharmaceutical care" |
27 | includes the judgment of a pharmacist in dispensing an equivalent and interchangeable drug or |
28 | device in response to a prescription, after appropriate communication with the prescriber and the |
29 | patient. |
30 | (r) "Pharmacist-in-charge" means a pharmacist licensed in this state as designated by the |
31 | owner as the person responsible for the operation of a pharmacy in conformance with all laws and |
32 | regulations pertinent to the practice of pharmacy and who is personally in full and actual charge |
33 | of such pharmacy and personnel. |
34 | (s) "Pharmacy" means that portion or part of a premise where prescriptions are |
| LC004581 - Page 3 of 5 |
1 | compounded and dispensed, including that portion utilized for the storage of prescription or |
2 | legend drugs. |
3 | (t) "Pharmacy technician" means an individual who meets minimum qualifications |
4 | established by the board, which are less than those established by this chapter as necessary for |
5 | licensing as a pharmacist, and works under the direction and supervision of a licensed pharmacist. |
6 | (u) "Practice of pharmacy" means the interpretation, evaluation, and implementation of |
7 | medical orders; the dispensing of prescription drug orders; participation in drug and device |
8 | selection; the compounding of prescription drugs; drug regimen reviews and drug or drug related |
9 | research; the administration of adult immunizations pursuant to a valid prescription or physician |
10 | approved protocol and in accordance with regulations, to include training requirements as |
11 | promulgated by the department of health; the administration of all forms of influenza |
12 | immunizations to individuals between the ages of nine (9) years and eighteen (18) years, |
13 | inclusive, pursuant to a valid prescription or prescriber approved protocol, in accordance with the |
14 | provisions of section 5-19.1-31 and in accordance with regulations, to include necessary training |
15 | requirements specific to the administration of influenza immunizations to individuals between the |
16 | ages of nine (9) years and eighteen (18) years, inclusive, as promulgated by the department of |
17 | health; provision of patient counseling and the provision of those acts or services necessary to |
18 | provide pharmaceutical care; and/or the responsibility for the supervision for compounding and |
19 | labeling of drugs and devices (except labeling by a manufacturer, repackager, or distributor of |
20 | non-prescription drugs and commercially packaged legend drugs and devices), proper and safe |
21 | storage of drugs and devices, and maintenance of proper records for them. Nothing in this |
22 | definition shall be construed to limit or otherwise affect the scope of practice of any other |
23 | profession. |
24 | (v) "Practitioner" means a physician, dentist, veterinarian, nurse, clinical pharmacist |
25 | practitioner, or other person duly authorized by law in the state in which they practice to prescribe |
26 | drugs. |
27 | (w) "Preceptor" means a pharmacist registered to engage in the practice of pharmacy in |
28 | this state, who has the responsibility for training interns. |
29 | (x) "Prescription" means an order for drugs or devices issued by the practitioner duly |
30 | authorized by law in the state in which he or she practices to prescribe drugs or devices in the |
31 | course of his or her professional practice for a legitimate medical purpose. |
32 | (y) "Wholesaler" means a person who buys drugs or devices for resale and distribution to |
33 | corporations, individuals, or entities other than consumers. |
| LC004581 - Page 4 of 5 |
1 | SECTION 2. This act shall take effect upon passage. |
======== | |
LC004581 | |
======== | |
| LC004581 - Page 5 of 5 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO BUSINESSES AND PROFESSIONS-PHARMACIES | |
*** | |
1 | This act would include "clinical pharmacist practitioners" within the definition of |
2 | "practitioner" for purposes of presenting drugs. |
3 | This act would take effect upon passage. |
======== | |
LC004581 | |
======== | |
| LC004581 - Page 6 of 5 |